Spain Oncology Biosimilars Market Analysis

Spain Oncology Biosimilars Market Analysis


$ 3999

Spain oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.

ID: IN10ESPH342 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Vidhi Upadhyay

Buy Now

Spain Oncology Biosimilars Market Analysis Summary

Spain Oncology Biosimilars Market is valued at around $75.8 Mn in 2022 and is projected to reach $318.6 Mn by 2030, exhibiting a CAGR of 19.67% during the forecast period 2023-2030.

The field of medicine known as oncology is focused on understanding, diagnosing, treating, and preventing cancer. It is a field that focuses on comprehending the complexity of cancer and creating efficient management and treatment plans for the illness. Oncologists are doctors who focus on the detection and management of cancer. A collection of disorders defined by the unchecked growth and spread of aberrant cells is referred to as cancer. These cells can penetrate and destroy healthy tissues, which can result in several difficulties and even fatalities. From the initial diagnosis to ongoing therapy, follow-up care, and palliative care for patients with advanced or terminal disease, oncologists play a critical role in every stage of cancer care. The global market is being driven by the increased incidence of cancer. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, Biogen International, Merck & Co., Inc., and Coherus Biosciences.

Market Dynamics

Market Growth Drivers

Two key factors driving the global market for oncology biosimilars are the increasing prevalence of different types of cancer and the associated demand for highly effective and precise treatment choices. When patients receive wrong and ineffective care, which is also expensive, the patient is put under further financial strain.

Market Restraints

The manufacturing complexities linked to oncology biosimilar products are the factors that are anticipated to restrain market expansion. Because biosimilars must go through additional clinical trials before receiving regulatory approval, regulatory and clinical challenges may also hinder market expansion.

Competitive Landscape

Key Players

  • Sandoz International GmbH
  • Celltrion Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Samsung Bioepis
  • Biogen International
  • Merck & Co., Inc.
  • Coherus Biosciences

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Spain Oncology Biosimilars Market Segmentation

By Drug Class

  • mAb (monoclonal antibodies)
  • G-CSF
  • Hematopoietic Agents
  • Others

By Type of Cancer

  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Cervical Cancer
  • Blood Cancer
  • Brain Cancer
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up